Share this article on:

CONTRIBUTORS

doi: 10.1212/01.CON.0000515626.32921.61
Contributors

Charles A. Zollinger, MD, FAAN, Guest Editor

Medical Director of Neurosciences and Stroke, Aultman Hospital, Canton, Ohio; Managing Partner of Information Technology, General Neurologist, NeuroCare Center, Inc, Canton, Ohio; Clinical Assistant Professor, Northeast Ohio Medical University, Rootstown, Ohio

aDr Zollinger serves as the associate editor of Continuum and has received personal compensation for serving as medical director for Aultman Hospital and as an owner and stockholder of NeuroCare Center, Inc.

bDr Zollinger reports no disclosure.

William P. Cheshire Jr, MD, FAAN

Professor of Neurology, Mayo Clinic, Jacksonville, Florida

aDr Cheshire serves as president of the American Autonomic Society and has served on the editorial boards of Autonomic Neuroscience: Basic and Clinical, Clinical Autonomic Research, and Parkinsonism & Related Disorders and has received personal compensation as a consultant for Biogen and Turner White Communications, Inc. Dr Cheshire has received research support from the Mayo Clinic.

bDr Cheshire discusses the unlabeled/investigational use of beta-blockers, fludrocortisone, and midodrine for the treatment of syncope.

Giorgio Cruccu, MD

Professor of Neurology, Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy

aDr Cruccu has received personal compensation for serving on the advisory board of and as a consultant for Angelini and Biogen, Inc and has received personal compensation for serving on the advisory board of and as a speaker for Sigma Tau Pharmaceuticals, Inc. Dr Cruccu has received research/grant support from Sapienza University of Rome and Sigma Tau Pharmaceuticals, Inc.

bDr Cruccu discusses the unlabeled/investigational use of BIIB074 for the treatment of elderly patients with trigeminal neuralgia.

Anindita Deb, MD

Assistant Professor, Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts

aDr Deb has received research/grant support as principle investigator of a study for the University of Massachusetts Office of Global Health and has given expert medical testimony as a neurology consultant.

bDr Deb reports no disclosure.

Ronald DeVere, MD, FAAN

Director, Taste and Smell Disorders Clinic; Director, Alzheimer's Disease and Memory Disorders Center, Austin, Texas

aDr DeVere has given expert medical testimony related to social security disability hearings and receives compensation from the federal government.

bDr DeVere reports no disclosure.

Terry D. Fife, MD, FAAN

Director of Vestibular Neurology and Balance Disorders; Vice Chairman of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital & Medical Center; Professor of Neurology, University of Arizona College of Medicine, Phoenix, Arizona

aDr Fife reports no disclosure.

bDr Fife discusses the unlabeled/investigational use of acetazolamide, venlafaxine, and zonisamide for the treatment of vestibular migraine.

Lisa D. Hobson-Webb, MD

Associate Professor of Neurology, Department of Neurology, Neuromuscular Division, Duke University School of Medicine, Durham, North Carolina

aDr Hobson-Webb has served on the editorial board of Clinical Neurophysiology and as an associate editor for Muscle & Nerve. Dr Hobson-Webb receives research/grant support from CSL Behring, the National Institute on Aging/Duke University Claude D. Pepper Older Americans Independence Center, and Sanofi Genzyme.

bDr Hobson-Webb reports no disclosure.

Vern C. Juel, MD, FAAN

Associate Professor of Neurology, Duke University School of Medicine, Durham, North Carolina

aDr Juel receives research/grant support as site investigator for studies for Alexion Pharmaceuticals, Inc and the National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases.

bDr Juel reports no disclosure.

Joseph S. Kass, MD, JD, FAAN

Associate Professor of Neurology, Psychiatry, and Medical Ethics; Vice Chair for Education, Department of Neurology; Associate Dean of Student Affairs, Baylor College of Medicine, Houston, Texas

aDr Kass serves as associate editor of ethical and medicolegal issues for Continuum and as an associate editor for Continuum Audio. Dr Kass has received personal compensation for CME and grand rounds lectures for MCE Conferences, Medical Education Speakers Network, and PrimeMed Medical Group and has received personal compensation for expert testimony in legal cases involving liability, malpractice, and personal injury.

bDr Kass reports no disclosure.

Kerry H. Levin, MD, FAAN

Chairman, Department of Neurology; Director, Neuromuscular Center, Cleveland Clinic, Cleveland Ohio; Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

aDr Levin receives personal compensation for serving as director of the American Board of Psychiatry and Neurology, serves on the editorial boards of Continuum and Muscle & Nerve, and receives publishing royalties from Elsevier and UpToDate, Inc.

bDr Levin reports no disclosure.

Jalesh N. Panicker, MD, DM, FRCP

Consultant in Neurology and Clinical Lead in Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital; Honorary Senior Lecturer, University College London Institute of Neurology, Queen Square, London, United Kingdom

aDr Panicker has received personal compensation for serving as a speaker for Astellas Pharma and for serving as an advisor for Wellspect Healthcare. Dr Panicker has received research/grant support as an investigator for Firstkind Limited, Multiple Sclerosis Society of the UK, and Parkinson’s UK, and has received publishing royalties from Cambridge University Press.

bDr Panicker reports no disclosure.

Stephen G. Reich, MD, FAAN

Frederick Henry Prince Distinguished Professor of Neurology, The University of Maryland School of Medicine, Baltimore, Maryland

aDr Reich serves as associate editor of the Journal of Clinical Movement Disorders and on the editorial board of Parkinsonism & Related Disorders.

Dr Reich has received publishing royalties from Informa, has received research support as an investigator for studies from the National Institute of Neurological Disorders and Stroke, and has given expert medical testimony in legal cases related to malpractice.

bDr Reich discusses the use of acyclovir and valacyclovir for the treatment of Bell’s palsy.

Rachel V. Rose, JD, MBA

Attorney, Rachel V. Rose Attorney at Law PLLC; Affiliated Faculty, Baylor College of Medicine, Houston, Texas

aMs Rose serves on the editorial board of BC Advantage and receives book royalties from the American Bar Association.

bMs Rose reports no disclosure.

Jinny O. Tavee, MD

Neuromuscular Fellowship Program Director; Associate Professor, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

aDr Tavee has received personal compensation for lectures from Mallinckrodt Pharmaceuticals and has received grant/research support for work in clinical trials from Araim Pharmaceuticals, Inc and Mallinckrodt Pharmaceuticals.

bDr Tavee reports no disclosure.

Allison L. Weathers, MD, FAAN

Associate Chief Medical Information Officer, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

aDr Weathers serves on the editorial board of Continuum and as chair of the adult neurosciences specialty steering board for Epic.

bDr Weathers reports no disclosure.

Lindsay A. Zilliox, MD, MS

Assistant Professor, University of Maryland School of Medicine; Neurologist, Baltimore VA Medical Center, Baltimore, Maryland

aDr Zilliox has received salary support from the US Department of Veterans Affairs Career Development Grant.

bDr Zilliox discusses the unlabeled/investigational use of duloxetine, gabapentin, lamotrigine, pregabalin, tricyclic antidepressants, valproic acid, and venlafaxine for the management of patients with neuropathic pain.

D. Joanne Lynn, MD, FAAN

Associate Dean for Student Life and Clinical Professor of Neurology, The Ohio State University College of Medicine, Columbus, Ohio

aDr Lynn receives book royalties from Lippincott Williams & Wilkins and holds stock in Abbott Laboratories; Bristol-Myers Squibb Company; Corning Incorporated; Express Scripts Holding Company; General Electric; Hospira, Inc; and Varian Medical Systems, Inc.

bDr Lynn reports no disclosure.

Joseph E. Safdieh, MD, FAAN

Louis and Rachel Rudin Education Scholar and Associate Professor of Neurology; Vice Chairman for Education, Department of Neurology, Weill Cornell Medical College, New York, New York

aDr Safdieh has received personal compensation for providing expert medical review in legal proceedings and has received publishing royalties from Elsevier.

bDr Safdieh reports no disclosure.

© 2017 American Academy of Neurology